Suppression of TRPM7 enhances TRAIL‐induced apoptosis in triple‐negative breast cancer cells
- 29 May 2020
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 235 (12), 10037-10050
- https://doi.org/10.1002/jcp.29820
Abstract
Transient receptor potential cation channel subfamily M member 7 (TRPM7) composed of an ion channel and a kinase domain regulates triple‐negative breast cancer (TNBC) cell migration, invasion, and metastasis, but it does not modulate TNBC proliferation. However, previous studies have shown that the combination treatment of nonselective TRPM7 channel inhibitors (2‐aminoethoxydiphenyl borate and Gd3+) with tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL) increases antiproliferative effects and apoptosis in prostate cancer cells and hepatic stellate cells. We, therefore, investigated the potential role of TRPM7 in proliferation and apoptosis of TNBC cells (MDA‐MB‐231 and MDA‐MB‐468 cells) with TRAIL. We demonstrated that suppression of TRPM7 via TRPM7 knockdown or pharmacological inhibition synergistically increases TRAIL‐induced antiproliferative effects and apoptosis in TNBC cells. Furthermore, we showed that the synergistic interaction might be associated with TRPM7 channel activities using combination treatments of TRAIL and TRPM7 inhibitors (NS8593 as a TRPM7 channel inhibitor and TG100‐115 as a TRPM7 kinase inhibitor). We reveal that downregulation of cellular FLICE‐inhibitory protein via inhibition of Ca2+ influx might be involved in the synergistic interaction. Our study would provide both a new role of TRPM7 in TNBC cell apoptosis and a potential combinatorial therapeutic strategy using TRPM7 inhibitors with TRAIL in the treatment of TNBC.Keywords
Funding Information
- National Research Foundation of Korea (NRF‐2016M3A9B5940991)
- Korea Institute of Science and Technology
This publication has 48 references indexed in Scilit:
- Upregulation of c-FLIP-short in response to TRAIL promotes survival of NSCLC cells, which could be suppressed by inhibition of Ca2+/calmodulin signalingCell Death & Disease, 2013
- ABT-737 promotes tBid mitochondrial accumulation to enhance TRAIL-induced apoptosis in glioblastoma cellsCell Death & Disease, 2012
- TRPM7 Is Required for Breast Tumor Cell MetastasisCancer Research, 2012
- Natural and synthetic modulators of SK (Kca2) potassium channels inhibit magnesium‐dependent activity of the kinase‐coupled cation channel TRPM7British Journal of Pharmacology, 2012
- Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAILBreast Cancer Research, 2011
- Evidence that TRPM7 is required for breast cancer cell proliferationAmerican Journal of Physiology-Cell Physiology, 2009
- c-FLIP knockdown induces ligand-independent DR5-, FADD-, caspase-8-, and caspase-9-dependent apoptosis in breast cancer cellsBiochemical Pharmacology, 2008
- Calmodulin binding to cellular FLICE-like inhibitory protein modulates Fas-induced signallingBiochemical Journal, 2008
- Inhibition of RIP and c-FLIP enhances TRAIL-induced apoptosis in pancreatic cancer cellsCellular Signalling, 2007
- Safety and antitumor activity of recombinant soluble Apo2 ligandJCI Insight, 1999